Literature DB >> 12573030

Versatile expression system for rapid and stable production of recombinant proteins.

M-S Cho1, H Yee, C Brown, B Mei, C Mirenda, S Chan.   

Abstract

Previously we reported the development of a novel expression system with Tat/TAR-oriP vectors and HKB11 cell line, which supports high level protein expression (Cho et al. Cytotechnology 2001, 37, 23-30). In the present study, we further demonstrated that HKB11 cells are suitable for high throughput expression (microgram scale) of genomic candidates in transient transfection system for in vitro evaluation of biological functions. HKB11 cells were also shown to support the production of milligram to gram quantities of protein drug candidates for in vivo evaluation of efficacy in various disease models. Stable HKB11 clones secreting high levels of a tissue factor (TF; 40-50 pg/c/d) and B-domain deleted recombinant factor VIII (BDDrFVIII; 5-10 microU/c/d) were derived under serum-free conditions. The specific productivity for these two proteins from the HKB11 cells was 10-fold greater than those from CHO cells derived under the similar conditions. In conclusion, we have demonstrated that the HKB11 cell line is well-suited for transient and long-term production of recombinant proteins.

Mesh:

Substances:

Year:  2003        PMID: 12573030     DOI: 10.1021/bp0255964

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  10 in total

Review 1.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

2.  Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Authors:  Baisong Mei; Yaoqi Chen; Jianmin Chen; Clark Q Pan; John E Murphy
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

3.  Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production.

Authors:  Sabine Geisse; Mario Henke
Journal:  J Struct Funct Genomics       Date:  2005

4.  Physiology and clinical pathology of laboratory new zealand white rabbits housed individually and in groups.

Authors:  Gabriela C Fuentes; James Newgren
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-03       Impact factor: 1.232

5.  Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring.

Authors:  Maria de Los Milagros Bassani Molinas; Christiane Beer; Friedemann Hesse; Manfred Wirth; Roland Wagner
Journal:  Cytotechnology       Date:  2013-06-18       Impact factor: 2.058

6.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

7.  Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII.

Authors:  Kamilla Swiech; Amine Kamen; Sven Ansorge; Yves Durocher; Virgínia Picanço-Castro; Elisa M S Russo-Carbolante; Mário S A Neto; Dimas T Covas
Journal:  BMC Biotechnol       Date:  2011-11-24       Impact factor: 2.563

8.  Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells.

Authors:  David L Hacker; Divor Kiseljak; Yashas Rajendra; Sarah Thurnheer; Lucia Baldi; Florian M Wurm
Journal:  Protein Expr Purif       Date:  2013-09-08       Impact factor: 1.650

9.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

Review 10.  Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives.

Authors:  Jennifer Dumont; Don Euwart; Baisong Mei; Scott Estes; Rashmi Kshirsagar
Journal:  Crit Rev Biotechnol       Date:  2015-09-18       Impact factor: 8.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.